Clinical Trials Logo

Hyperemesis Gravidarum clinical trials

View clinical trials related to Hyperemesis Gravidarum.

Filter by:

NCT ID: NCT01559012 Completed - Clinical trials for Hyperemesis Gravidarum

Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum

CLONEMESI
Start date: February 2012
Phase: Phase 3
Study type: Interventional

CLONEMESI is an academic, independent, randomized placebo-controlled trial to assess the effect of transdermal (TD) clonidine in improving the symptoms of severe Hyperemesis Gravidarum(HG) affecting women in their 6th-12th week of pregnancy. The study has a crossover design.

NCT ID: NCT00795561 Completed - Pregnancy Clinical Trials

Management of Nausea and Vomiting of Pregnancy

DIM
Start date: April 2009
Phase: N/A
Study type: Interventional

Upto 80% of all pregnant women experience some form of nausea and vomiting (NVP) during their pregnancy. Hyperemesis gravidarum, a more severe form of NVP affects approximately 0.3- 2.0% of pregnancies and is the commonest indication for admission to hospital in the first half of pregnancy and second only to preterm labor as a cause of hospitalization overall. According to the Hyperemesis Education and Research Foundation, conservative estimates indicate that HG can cost a minimum of $200 million annually in house hospitalizations in the United States of America. The investigators aim to conduct a randomized controlled trial to test the hypothesis that the availability of day care services for the initial treatment of NVP reduces the mean duration of stay in hospital by 1 day and results in significantly greater patient satisfaction compared with standard inpatient management.

NCT ID: NCT00293644 Completed - Pregnancy Clinical Trials

Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy

Start date: February 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether pre-emptive use of a delayed release combination of pyridoxine hydrochloride and doxylamine succinate (Diclectin®), before eruption of symptoms of Nausea and vomiting of pregnancy and hyperemesis gravidarum, will reduce the incidence of severe forms of this syndrome/HG.